Analysis of DCIS using Clariom D transcriptomics array

ABSTRACT: Experiment description to give context to the data set: Ductal carcinoma in situ (DCIS), the most common type of pre-invasive lesion of breast, is being detected with increasing frequency with the advent of mammographic screening. Surgery is the mainstay for the treatment of DCIS. Based on the clinic-pathological features of DCIS, this may be followed by radiotherapy and/or endocrine therapy. The qualitative assessment of histological grade, expression of single protein biomarkers and more recently, mRNA analysis (DCIS Score) have been used to make these decisions. However, these factors do not fully predict the likelihood of development of invasive breast cancer treated with breast-conserving surgery. A majority of women with ductal carcinoma in situ (DCIS) receive breast-conserving surge

ORGANISM(S): Homo sapiens

SUBMITTER: Sunil Badve S 

PROVIDER: E-MTAB-9856 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress